• English
  • Italiano
HEAL ITALIA
  • Foundation
    • Who we are
    • management and organization
      • General Management
      • Governance
    • advisory committees
      • Scientific committee
      • Steering Committee
      • Advisory Board
    • Spoke
      • Spoke 1: Omics
      • Spoke 2: Data
      • Spoke 3: Models
      • Spoke 4: Diagnosis
      • Spoke 5: Therapy
      • Spoke 6: Devices
      • Spoke 7: Prevention
      • Spoke 8: Clinical
    • Partner
    • Contacts
  • Events
    • Heal Italia Roadshow
    • Heal Italia abroad
  • Services
    • Training
    • Technology Transfer
    • International positioning
  • Core Facilities
    • Biobanks
  • Open Science
    • Open Science Area
    • Open Science Publications
    • Publication Highlights
  • Announcements
    • Notices
    • Cascade Calls
    • Cascade Call Projects
    • FAQ
  • News
    • Featured
    • Newsletter
    • Press review

Cerca nel sito

nanomedicine

Er:Y2O3 and Nd:Y2O3 Nanoparticles: Synthesis, Pegylation, Characterization and Study of Their Luminescence Properties

Er:Y2O3 and Nd:Y2O3 Nanoparticles: Synthesis, Pegylation, Characterization and Study of Their Luminescence Properties


Nanomedicine | 2023

Regina Maria Chiechio ,Rosalia Battaglia, Angela Caponnetto, Ester Butera, Giorgia Franzò, Riccardo Reitano, Michele Purrello, Marco Ragusa, Davide Barbagallo, Cristina Barbagallo, Cinzia Di Pietro, Valérie Marchi, Maria José Lo Faro, Annalinda Contino, Giuseppe Maccarrone andPaolo Musumeci

Fondazione HEAL ITALIA
Sede Operativa: Via Isidoro La Lumia 19C, Palermo PA
Complesso Monumentale dello Steri,
Piazza Marina, 61, Palermo PA
healitalia@gmail.com

Dona il tuo 5×1000 alla ricerca
Codice Fiscale Heal Italia: 97370050821

  • Home
  • Rassegna Stampa
  • Fondazione trasparente
  • Partner
  • News
  • Chi siamo
  • Privacy policy
  • Kit di comunicazione Heal Italia

Questo sito è stato sviluppato dalla Fondazione HEAL ITALIA nell’ambito del progetto finanziato dall’Unione europea – (NextGenerationEU) – PNRR Missione 4, Componente 2, Investimento 1.3.